[
  {
    "ts": null,
    "headline": "CVS Reiterates 2026 Profit Outlook, Shares Slide 3.7% Despite Q4 Beat",
    "summary": "The company maintained its 2026 earnings forecast, with guidance falling short of expectations despite stronger fourth-quarter results.",
    "url": "https://finnhub.io/api/news?id=1be8fc155be97964b86c03993a97d33138e7a4c22af1ed8163e1361b94c46b13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770750838,
      "headline": "CVS Reiterates 2026 Profit Outlook, Shares Slide 3.7% Despite Q4 Beat",
      "id": 139034920,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "The company maintained its 2026 earnings forecast, with guidance falling short of expectations despite stronger fourth-quarter results.",
      "url": "https://finnhub.io/api/news?id=1be8fc155be97964b86c03993a97d33138e7a4c22af1ed8163e1361b94c46b13"
    }
  },
  {
    "ts": null,
    "headline": "Salesforce and 10 More Stocks That Have Cratered and Look Like Buys",
    "summary": "Evercore strategist Julian Emanuel listed a bunch of examples.  A cohort of other healthcare stocks have been crushed as well, including providers of data-centric tools that pharmaceutical companies use to create new drugs.",
    "url": "https://finnhub.io/api/news?id=4187dfb95bfca6a821e680fb19fac7ca78ef8db3234884010e89203b6d284c94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770747480,
      "headline": "Salesforce and 10 More Stocks That Have Cratered and Look Like Buys",
      "id": 139034921,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Evercore strategist Julian Emanuel listed a bunch of examples.  A cohort of other healthcare stocks have been crushed as well, including providers of data-centric tools that pharmaceutical companies use to create new drugs.",
      "url": "https://finnhub.io/api/news?id=4187dfb95bfca6a821e680fb19fac7ca78ef8db3234884010e89203b6d284c94"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth: After The Collapse",
    "summary": "UnitedHealth Group Incorporated guides 2026 revenue to $439 billion, down from $448 billion. Click here to read why UNH stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=92984339771cfd4a699890398ea6ceaa0cff560bcbec976fb89df7a0a88cf3fd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770737262,
      "headline": "UnitedHealth: After The Collapse",
      "id": 139035443,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1893412958/image_1893412958.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "UnitedHealth Group Incorporated guides 2026 revenue to $439 billion, down from $448 billion. Click here to read why UNH stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=92984339771cfd4a699890398ea6ceaa0cff560bcbec976fb89df7a0a88cf3fd"
    }
  },
  {
    "ts": null,
    "headline": "Here’s What Happened to UnitedHealth Group (UNH)",
    "summary": "Ruane, Cunniff LP, an investment adviser managing Sequoia Strategy, released its Q4 2025 investor letter. A copy of the letter can be downloaded here. Sequoia Strategy returned 9% in Q4 compared to 2.7% for the S&P 500 Index. The Strategy delivered a return of 21.9% in 2025 versus 17.9% for the Index. In a year […]",
    "url": "https://finnhub.io/api/news?id=5e77b5b81556b6846bc672961e5710361af476ffce740c2827b8c4465d788607",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770728240,
      "headline": "Here’s What Happened to UnitedHealth Group (UNH)",
      "id": 139029610,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Ruane, Cunniff LP, an investment adviser managing Sequoia Strategy, released its Q4 2025 investor letter. A copy of the letter can be downloaded here. Sequoia Strategy returned 9% in Q4 compared to 2.7% for the S&P 500 Index. The Strategy delivered a return of 21.9% in 2025 versus 17.9% for the Index. In a year […]",
      "url": "https://finnhub.io/api/news?id=5e77b5b81556b6846bc672961e5710361af476ffce740c2827b8c4465d788607"
    }
  },
  {
    "ts": null,
    "headline": "Some Investors May Be Worried About UnitedHealth Group's (NYSE:UNH) Returns On Capital",
    "summary": "To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...",
    "url": "https://finnhub.io/api/news?id=e5b55f1b4fef75aa0ae08d0e1fab0ff4f65f108fe78c31a55872e6f8e87ec133",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770724808,
      "headline": "Some Investors May Be Worried About UnitedHealth Group's (NYSE:UNH) Returns On Capital",
      "id": 139029611,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...",
      "url": "https://finnhub.io/api/news?id=e5b55f1b4fef75aa0ae08d0e1fab0ff4f65f108fe78c31a55872e6f8e87ec133"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health beats quarterly profit expectations on pharmacy performance",
    "summary": "Feb 10 () - CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped by strength in its pharmacy benefit unit and strong prescription ​volume at its retail pharmacies. CVS said adjusted quarterly profit fell to $1.",
    "url": "https://finnhub.io/api/news?id=a59d0e024eb4ffac7d847dd299fbcfa5a989f05b720b4ac8e4e8290dc868cc89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770723252,
      "headline": "CVS Health beats quarterly profit expectations on pharmacy performance",
      "id": 139028455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Feb 10 () - CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped by strength in its pharmacy benefit unit and strong prescription ​volume at its retail pharmacies. CVS said adjusted quarterly profit fell to $1.",
      "url": "https://finnhub.io/api/news?id=a59d0e024eb4ffac7d847dd299fbcfa5a989f05b720b4ac8e4e8290dc868cc89"
    }
  }
]